Legislative Advocacy

IPC and a coalition of pharmacy organizations released a statement before Tuesday's U.S. House Oversight hearing on PBM tactics.

FTC's July 2024 report reveals PBMs inflating drug costs, squeezing community pharmacies, and impacting patient access.

The FDA has announced critical updates on the implementation of the Drug Supply Chain Security Act (DSCSA).

IPC champions community pharmacies in pivotal Ohio case.

Transforming pharmacy benefits for better patient care. Learn how states are leading the charge.

IPC lobbies for policies to help community pharmacy during their recent fly-in to Washington D.C.

Getting involved with government relations doesn’t have to be complicated for pharmacy owners, IPC is here to help.

AB 317 empowers California pharmacists. IPC leads PBM reform advocacy. FDA mandates DSCSA compliance. Stay updated with critical healthcare news.

The FTC has announced an investigation into the practices of PBMs after more than 24,000 comments were submitted to the agency.

Earlier this month the FTC extended the deadline for submitting comments on the practices of Pharmacy Benefit Managers.